Ceva Stresses Need for Further Innovation in Hatchery Vaccination
US - Ceva teams will use this year’s International Poultry Expo, the world's largest poultry exhibition, to promote the latest technological advances in hatchery vaccination.
25 January 2013
2 minute read
For the first
time, a single, combined dose of vaccine given in the hatchery can produce life-long
protection against Newcastle and Gumboro diseases. Ceva calls this significant step forward,
using Vectormune® ND and Transmune® IBD – The "Perfect Pair."
Every month the world’s population grows by a city the size of London and to meet this
demand poultry production is predicted to rise 60 per cent by 2030.
Ceva has a complete line of vector vaccines, the largest registered in the USA. These new
technology vaccines in addition to equipment and expert services combine to provide the
most innovative offer to the hatchery. Each small advance will contribute to making poultry
production more efficient and sustainable, therefore contributing to the challenge of feeding
a growing world population.
Ceva will be glad to welcome you at Booth # 639 Hall B.
 |
Further ReadingFind out more information on the diseases mentioned here by clicking here. |
